$3.58 Billion is the total value of Rubric Capital Management LP's 57 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PARR | PAR PAC HOLDINGS INC | $58,164,000 | -6.5% | 3,700,000 | 0.0% | 1.63% | -58.5% | |
| TAC | TRANSALTA CORP | $54,816,000 | +6.0% | 5,189,062 | 0.0% | 1.53% | -52.9% | |
| GEF | GREIF INCcl a | $46,835,000 | +6.7% | 725,000 | 0.0% | 1.31% | -52.6% | |
| GPRE | GREEN PLAINS INC | $43,468,000 | -2.9% | 1,331,330 | 0.0% | 1.22% | -56.8% | |
| COOP | MR COOPER GROUP INC | $26,193,000 | +24.5% | 636,221 | 0.0% | 0.73% | -44.7% | |
| MTG | MGIC INVT CORP WIS | $22,754,000 | +10.0% | 1,521,006 | 0.0% | 0.64% | -51.2% | |
| RDN | RADIAN GROUP INC | $21,320,000 | +2.1% | 938,368 | 0.0% | 0.60% | -54.6% | |
| MX | MAGNACHIP SEMICONDUCTOR CORP | $15,492,000 | -25.6% | 872,308 | 0.0% | 0.43% | -66.9% | |
| HY | HYSTER YALE MATLS HANDLING Icl a | $11,133,000 | -31.1% | 221,514 | 0.0% | 0.31% | -69.4% | |
| SIOX | SIO GENE THERAPIES INC | $6,510,000 | -20.5% | 3,000,000 | 0.0% | 0.18% | -64.7% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $2,410,000 | -16.3% | 663,856 | 0.0% | 0.07% | -63.0% | |
| REPH | RECRO PHARMA INC | $2,218,000 | -10.8% | 1,076,587 | 0.0% | 0.06% | -60.5% | |
| VIAO | VIA OPTRONICS AGsponsored ads | $1,929,000 | -31.7% | 251,855 | 0.0% | 0.05% | -69.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DFAN14A | 2024-05-08 |
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
| PRRN14A | 2024-04-02 |
| PRRN14A | 2024-03-26 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.